Semper Paratus Acquisition Corp
Status: Closed Deal
U=S+W/2
W=S@11.50
| IPO Proceeds, $M | $345.00M |
|---|---|
| IPO Date | Nov 4, 2021 |
| CEO | Surendra Ajjarapu |
| Left Lead | Cantor Fitzgerald |
| IPO Cash in Trust | 102.0% |
| SPAC Tenor | 15 + 10 + 9 |
| IPO Sector | Industrial ▶ |
| IPO Geography | Global |
| Target Company | Tevogen Bio |
| Deal Announced | Jun 29, 2023 |
| Deal Size, $M | $1,200.00M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Jan 29, 2024 |
| Amendment Vote | Dec 14, 2023 |
| Closing Date | Feb 14, 2024 |
Formerly LGST
TVGN
TVGNW
| Price | $1.00 |
|---|---|
| Last closing price | $0.94 |
| H/L, today | $0.96 / $1.10 |
| Volume, today | 12,339,581 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.